Quality & complianceOfficial
Infarmed orders recall of Entecavir Viatris batches over active substance contamination concerns
🇵🇹 INFARMED · Thu 19 Nov 2026
Portugal's medicines authority has suspended distribution of affected batches after a partner regulator found manufacturing non-conformities at the active substance stage, citing potential contamination and cross-contamination.
Infarmed, the Portuguese medicines regulator, has ordered the recall of certain batches of Entecavir Viatris and the immediate suspension of their distribution. The instruction was issued on 19 November 2026 in Informative Circular No. 108/CD/550.20.001. Entecavir is an antiviral used to treat chronic hepatitis B.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (INFARMED). AI-assisted; check the source before acting.
More Quality & compliance
All →
Terumo Aortic recalls all in-date Relay Pro and Treo stent-graft systems over endotoxin risk
🇨🇦 Health Canada · Fri 20 Nov 2026
FDA says clinical investigator's CAPA response falls short after CBER warning letter
🇺🇸 FDA CBER · Fri 20 Nov 2026
BfArM publishes GE Healthcare urgent field safety notice for Centricity PACS and Enterprise Archive
🇩🇪 BfArM field safety notices · Fri 20 Nov 2026
New Jersey health centre owner jailed for 180 days over billing fraud and unlicensed practice
🇺🇸 HHS OIG · Fri 20 Nov 2026
Richmond couple sentenced over Medicaid mental health billing scheme worth nearly $1m
🇺🇸 HHS OIG · Fri 20 Nov 2026
InnovAge settles Colorado Medicaid false claims allegations over senior care services
🇺🇸 HHS OIG · Fri 20 Nov 2026